139 related articles for article (PubMed ID: 1963641)
21. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].
Poulain B
Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455
[TBL] [Abstract][Full Text] [Related]
22. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
Popoff MR; Marvaud JC; Raffestin S
Ann Pharm Fr; 2001 May; 59(3):176-90. PubMed ID: 11427819
[TBL] [Abstract][Full Text] [Related]
23. [Structure and function of botulinum toxin].
Fujii N
Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
[TBL] [Abstract][Full Text] [Related]
24. Molecular targets of botulinum toxin at the mammalian neuromuscular junction.
Whelchel DD; Brehmer TM; Brooks PM; Darragh N; Coffield JA
Mov Disord; 2004 Mar; 19 Suppl 8():S7-S16. PubMed ID: 15027049
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of neurotransmitter release by clostridial neurotoxins correlates with specific proteolysis of synaptosomal proteins.
Blasi J; Binz T; Yamasaki S; Link E; Niemann H; Jahn R
J Physiol Paris; 1994; 88(4):235-41. PubMed ID: 7874084
[TBL] [Abstract][Full Text] [Related]
26. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
Wang SJ
Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxins: mechanisms of action, antinociception and clinical applications.
Wheeler A; Smith HS
Toxicology; 2013 Apr; 306():124-46. PubMed ID: 23435179
[TBL] [Abstract][Full Text] [Related]
28. Transmitter release in botulinum-poisoned muscles.
Thesleff S
J Physiol (Paris); 1984; 79(4):192-5. PubMed ID: 6152289
[TBL] [Abstract][Full Text] [Related]
29. Microtubules and microfilaments participate in the inhibition of synaptosomal noradrenaline release by tetanus toxin.
Ashton AC; Dolly JO
J Neurochem; 1997 Feb; 68(2):649-58. PubMed ID: 9003052
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the inhibitory action of botulinum neurotoxin type A on the release of several transmitters from rat cerebrocortical synaptosomes.
Ashton AC; Dolly JO
J Neurochem; 1988 Jun; 50(6):1808-16. PubMed ID: 2897427
[TBL] [Abstract][Full Text] [Related]
31. A late phase of exocytosis from synaptosomes induced by elevated [Ca2+]i is not blocked by Clostridial neurotoxins.
Ashton AC; Dolly JO
J Neurochem; 2000 May; 74(5):1979-88. PubMed ID: 10800941
[TBL] [Abstract][Full Text] [Related]
32. Botulinum neurotoxins: mechanism of action.
Tighe AP; Schiavo G
Toxicon; 2013 Jun; 67():87-93. PubMed ID: 23201505
[TBL] [Abstract][Full Text] [Related]
33. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves.
Black JD; Dolly JO
J Cell Biol; 1986 Aug; 103(2):521-34. PubMed ID: 3733877
[TBL] [Abstract][Full Text] [Related]
34. Botulinum A like type B and tetanus toxins fulfils criteria for being a zinc-dependent protease.
de Paiva A; Ashton AC; Foran P; Schiavo G; Montecucco C; Dolly JO
J Neurochem; 1993 Dec; 61(6):2338-41. PubMed ID: 8245989
[TBL] [Abstract][Full Text] [Related]
35. Light chain of botulinum neurotoxin is active in mammalian motor nerve terminals when delivered via liposomes.
de Paiva A; Dolly JO
FEBS Lett; 1990 Dec; 277(1-2):171-4. PubMed ID: 2176612
[TBL] [Abstract][Full Text] [Related]
36. Isolated light chains of botulinum neurotoxins inhibit exocytosis. Studies in digitonin-permeabilized chromaffin cells.
Bittner MA; DasGupta BR; Holz RW
J Biol Chem; 1989 Jun; 264(18):10354-60. PubMed ID: 2732226
[TBL] [Abstract][Full Text] [Related]
37. The structure and mode of action of different botulinum toxins.
Dolly JO; Aoki KR
Eur J Neurol; 2006 Dec; 13 Suppl 4():1-9. PubMed ID: 17112344
[TBL] [Abstract][Full Text] [Related]
38. Vesicle exocytosis stimulated by alpha-latrotoxin is mediated by latrophilin and requires both external and stored Ca2+.
Davletov BA; Meunier FA; Ashton AC; Matsushita H; Hirst WD; Lelianova VG; Wilkin GP; Dolly JO; Ushkaryov YA
EMBO J; 1998 Jul; 17(14):3909-20. PubMed ID: 9670008
[TBL] [Abstract][Full Text] [Related]
39. On the action of botulinum neurotoxins A and E at cholinergic terminals.
Washbourne P; Pellizzari R; Rossetto O; Bortoletto N; Tugnoli V; De Grandis D; Eleopra R; Montecucco C
J Physiol Paris; 1998 Apr; 92(2):135-9. PubMed ID: 9782457
[TBL] [Abstract][Full Text] [Related]
40. [Botulinum neurotoxin].
Poulain B
Rev Neurol (Paris); 2010 Jan; 166(1):7-20. PubMed ID: 19846187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
